Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

INTRODUCTION: Ankylosing spondylitis (AS) is a chronic rheumatic disease associated with spinal inflammation that subsequently leads to progression of structural damage and loss of function. The fully human anti-tumor necrosis factor (anti-TNF) antibody adalimumab reduces the signs and symptoms and...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: van der Heijde, Désirée, Salonen, David, Weissman, Barbara N, Landewé, Robert, Maksymowych, Walter P, Kupper, Hartmut, Ballal, Shaila, Gibson, Eric, Wong, Robert
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2009
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2745811/
https://ncbi.nlm.nih.gov/pubmed/19703304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2794
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky